An index of frontier and emerging AI labs.
Bio / AI drug discovery
Small-molecule drug-discovery lab combining high-throughput chemistry, computation, and generative AI at data scale. Closed a $120M Series B in October 2024 to advance its pipeline toward the clinic.
| Name | Terray Therapeutics |
|---|---|
| Space | Bio / AI drug discovery |
| Founded | 2022 |
| Latest valuation | — |
| Stage | — |
| Status | active |
| HQ | Monrovia, CA |
| Founders | Jacob Berlin, Eli Berlin |
| Website | https://www.terraytx.com |
| Careers | https://www.terraytx.com/careers |
| — | |
| X / Twitter | — |
No funding events recorded.
No founders recorded yet. Submit info.
| Date | Type | Title | Source |
|---|---|---|---|
| 2026-06-14 | added | Terray Therapeutics added to tracker | — |
No sources cited.
| Lab | Valuation | Founded |
|---|---|---|
| Isomorphic Labs | >$15B | 2021 |
| Xaira Therapeutics | ~$4B | 2024 |
| insitro | ~$2.5B | 2018 |
| Generate Biomedicines | ~$2B | 2018 |
| Recursion | ~$1.75B (mkt cap) | 2013 |
| Chai Discovery | $1.3B | 2024 |
| Earendil Labs | ~$1B | 2023 |
| EvolutionaryScale | >$1B | 2024 |